Cargando…

CD38 and Regulation of the Immune Response Cells in Cancer

Cancer is a leading cause of death worldwide. Understanding the functional mechanisms associated with metabolic reprogramming, which is a typical feature of cancer cells, is key to effective therapy. CD38, primarily a NAD + glycohydrolase and ADPR cyclase, is a multifunctional transmembrane protein...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dwivedi, Sanyog, Rendón-Huerta, Erika P., Ortiz-Navarrete, Vianney, Montaño, Luis F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2021
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7936891/ https://www.ncbi.nlm.nih.gov/pubmed/33727923 http://dx.doi.org/10.1155/2021/6630295

Ejemplares similares

Chromosomally Unstable Gastric Cancers Overexpressing Claudin-6 Disclose Cross-Talk between HNF1A and HNF4A, and Upregulated Cholesterol Metabolism
por: Dwivedi, Sanyog, et al.
Publicado: (2022)

Proteolytic Processing of CD44 and Its Implications in Cancer
por: Medrano-González, Priscila Anhel, et al.
Publicado: (2021)

Salmonella Modulates B Cell Biology to Evade CD8(+) T Cell-Mediated Immune Responses
por: Lopez-Medina, Marcela, et al.
Publicado: (2014)

Binding of YY1/CREB to an Enhancer Region Triggers Claudin 6 Expression in H. pylori LPS-Stimulated AGS Cells
por: Romero-Estrada, Jorge H., et al.
Publicado: (2023)

CD38 Correlates with an Immunosuppressive Treg Phenotype in Lupus-Prone Mice
por: Pérez-Lara, Jocelyn C., et al.
Publicado: (2021)

Roles of CD38 in the Immune Response to Infection
por: Glaría, Estibaliz, et al.
Publicado: (2020)

Hypothyroidism in Noninterferon Treated-HCV Infected Individuals Is Associated with Abnormalities in the Regulation of Th17 Cells
por: Salazar, Luis A., et al.
Publicado: (2010)

IL-17-producing peripheral blood CD177(+) neutrophils increase in allergic asthmatic subjects
por: Ramirez-Velazquez, Carlos, et al.
Publicado: (2013)

CD38 is methylated in prostate cancer and regulates extracellular NAD(+)
por: Mottahedeh, Jack, et al.
Publicado: (2018)

EZH2 targeting induces CD38 upregulation and response to anti-CD38 immunotherapies in multiple myeloma
por: Chemlal, Djamila, et al.
Publicado: (2023)

CD38 in Advanced Prostate Cancers
por: Guo, Christina, et al.
Publicado: (2021)

CD38 ecto-enzyme in immune cells is induced during aging regulating NAD(+) and NMN levels
por: Chini, Claudia C.S., et al.
Publicado: (2020)

CD38: A Significant Regulator of Macrophage Function
por: Li, Wentao, et al.
Publicado: (2022)

Functional assessment of the cell-autonomous role of NADase CD38 in regulating CD8(+) T cell exhaustion
por: Ma, Kaili, et al.
Publicado: (2022)

Regulation of CD38 on Multiple Myeloma and NK Cells by Monoclonal Antibodies
por: Wu, Hao-Tian, et al.
Publicado: (2022)

p38γ and p38δ modulate innate immune response by regulating MEF2D activation
por: Escós, Alejandra, et al.
Publicado: (2023)

Dysregulated CD38 Expression on Peripheral Blood Immune Cell Subsets in SLE
por: Burns, Marie, et al.
Publicado: (2021)

CD200 Modulates S. aureus-Induced Innate Immune Responses Through Suppressing p38 Signaling
por: Zhu, Bo, et al.
Publicado: (2019)

CD38 and Anti-CD38 Monoclonal Antibodies in AL Amyloidosis: Targeting Plasma Cells and beyond
por: Roccatello, Dario, et al.
Publicado: (2020)

Daratumumab induces mechanisms of immune activation through CD38+ NK cell targeting
por: Viola, Domenico, et al.
Publicado: (2020)

CD38 Predicts Favorable Prognosis by Enhancing Immune Infiltration and Antitumor Immunity in the Epithelial Ovarian Cancer Microenvironment
por: Zhu, Ying, et al.
Publicado: (2020)

Responses of CD27(+)CD38(+) plasmablasts, and CD24(hi)CD27(hi) and CD24(hi)CD38(hi) regulatory B cells during primary dengue virus 2 infection
por: Lei, Chenshuang, et al.
Publicado: (2021)

Phenotyping and Target Expression Profiling of CD34(+)/CD38(−) and CD34(+)/CD38(+) Stem- and Progenitor cells in Acute Lymphoblastic Leukemia
por: Blatt, Katharina, et al.
Publicado: (2018)

CD38 in Neurodegeneration and Neuroinflammation
por: Guerreiro, Serge, et al.
Publicado: (2020)

Dysregulated CD38 expression in blood and skin immune cells of patients with hidradenitis suppurativa
por: Mi, Qing-Sheng, et al.
Publicado: (2023)

Immune and pathologic responses in patients with localized prostate cancer who received daratumumab (anti-CD38) or edicotinib (CSF-1R inhibitor)
por: Siddiqui, Bilal A, et al.
Publicado: (2023)

IFN-γ and CD38 in Hyperprogressive Cancer Development
por: Angelicola, Stefania, et al.
Publicado: (2021)

Targeting CD38 in Neoplasms and Non-Cancer Diseases
por: Szlasa, Wojciech, et al.
Publicado: (2022)

Immunomodulation Induced During Interferon-α Therapy Impairs the Anti-HBV Immune Response Through CD24(+)CD38(hi) B Cells
por: Fu, Binqing, et al.
Publicado: (2020)

CD38(+)CD39(+) NK cells associate with HIV disease progression and negatively regulate T cell proliferation
por: Qian, Shi, et al.
Publicado: (2022)

CD38 regulates ovarian function and fecundity via NAD(+) metabolism
por: Perrone, Rosalba, et al.
Publicado: (2023)

Peripheral blood T cells and neutrophils from asthma patients express class-I MHC-restricted T cell-associated molecule
por: Ramirez-Velazquez, Carlos, et al.
Publicado: (2014)

The Roles of CD38 and CD157 in the Solid Tumor Microenvironment and Cancer Immunotherapy
por: Wo, Yu Jun, et al.
Publicado: (2019)

Regulation of the cd38 promoter in human airway smooth muscle cells by TNF-α and dexamethasone
por: Tirumurugaan, Krishnaswamy G, et al.
Publicado: (2008)

Controversy in the Use of CD38 Antibody for Treatment of Myeloma: Is High CD38 Expression Good or Bad?
por: Plesner, Torben, et al.
Publicado: (2020)

CD38: T Cell Immuno-Metabolic Modulator
por: Kar, Anwesha, et al.
Publicado: (2020)

CD38 Multi-Functionality in Oral Squamous Cell Carcinoma: Prognostic Implications, Immune Balance, and Immune Checkpoint
por: Ding, Zhuang, et al.
Publicado: (2021)

Interferon gamma selectively inhibits very primitive CD342+CD38- and not more mature CD34+CD38+ human hematopoietic progenitor cells
Publicado: (1994)

CD24(+)/CD38(-) as new prognostic marker for non-small cell lung cancer
por: Karimi-Busheri, Feridoun, et al.
Publicado: (2013)

The Good, the Bad and the Unknown of CD38 in the Metabolic Microenvironment and Immune Cell Functionality of Solid Tumors
por: Konen, Jessica M., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_uv58b19aa80h3t11p9babvahs4